Skip to main content

Sleep Disorder Therapeutics Market Forecasted to Grow at Steady Pace During 2015-2021

Sleep disorders include a variety of complications related to sleep and have a high prevalence across the globe. Based on these complications, sleep disorders can be classified into three categories- lack of sleep which includes insomnia, excessive sleep which includes narcolepsy and disturbed sleep which include sleep apnea and Rapid eye movement (REM) disorder. Insomnia may arise as result of unhealthy diet, emotional dreams, stress, and many other factors.
Insomnia may affect reaction time towards common stimulus, hand-eye coordination, memory, and disturb daily life. Narcolepsy is a disorder that causes uncontrolled sleep at time period lasting less than minute or more than an hour. It has also been found that patients with narcolepsy experience sleep attacks more often during pregnancy, stress or ill health.
Request For Report Sample@ https://www.persistencemarketresearch.com/samples/5714
Usually narcolepsy is a genetic disease, but it has also been found to develop as a result of some neurological disorders or severe brain damage. REM sleep behavior disorder involves abnormal behavior in sleep. In this disorder, a patient dreaming about running, may run while still asleep. Sleep apnea is obstructed breathing during sleep.
According to a press release in March 2014 by World Association of Sleep Medicine, 45% of the global population suffers from some form of sleep disorder. It also mentions that approximately 25% male and 10% females in the U.S. suffer from sleep apnea. This high prevalence suggests an opportunity for a large therapeutics market.
Currently marketed drugs include Sanofi-Aventis manufactured Ambien (zolpidem), Sunovion Pharmaceuticals Inc.’s Lunesta (eszopiclone), Takeda Pharmaceutical’s Rozerem (ramelteon), Somaxon Pharmaceuticals, Inc.’s Silenor (doxepine) and various others. Over-the-counter drugs are also available for treating sleep disorder; these include
  • Nytol,
  • Sominex,
  • Compoz, and
  • Unisom.
Merck’s Suvorexant drug is an orexin receptor agonist which is under Phase III trial. Other companies involved in the drug development of sleep disorder include
  • Vanda Pharmaceuticals,
  • Eli Lilly,
  • GlaxoSmithKline and
  • Neurim Pharmaceuticals.
Request For Report Table of Content (TOC)@ https://www.persistencemarketresearch.com/toc/5714
Key geographies evaluated in this report are:
  • North America
    • U.S
    • Canada
  • Europe
    • France, Germany, Italy, Spain, and the UK
    • Eastern Europe
    • CIS
  • APAC
    • China
    • India
    • Japan
    • Australia
    • Others
  • Latin America
    • Argentina
    • Brazil
    • Others
Key features of this report
  • Drivers, restraints, and challenges shaping the Sleep Disorder Therapeutics market dynamics
  • Latest innovations and key events in the industry
  • Analysis of business strategies of the top players
  • Sleep Disorder Therapeutics market estimates and forecasts(2015 -2021)
Know More About Report@ https://www.persistencemarketresearch.com/market-research/sleep-disorder-therapeutics-market.asp
Labels:

Comments

Post a Comment

Popular posts from this blog

Business analytics software increasing due to Low Cost & Enhanced Usability

  Business analytics software   conducts predictive analysis to derive decision-making inputs and insights through the application of statistical tools and methods in business performance data. It analyzes business data and information through continuous investigation and exploration of old business performance data to obtain decisive insights for business planning. A business analytics software helps an organization to optimize business operations and facilitates strategic decision-making. The outputs are mostly used by financial analysts, managers, security personnel, and key decision makers of organizations. The demand for cloud-based business analytics software is increasing among small- and medium-sized enterprises chiefly due to its low cost and enhanced usability. Request for Sample Copy @  https://bit.ly/3gRxTjw The growth of the global business analytics software market is driven by factors such as increase in adoption of business analytics software by multiple o...
Post a Comment
Read more

Airline Booking Platform boosting in Europe Country

  Europe leads the   airline booking platform   market by region. European region consists of highly developed countries, which are witnessing high growth in their airline sector. With more than 20,000 flights a day and approximately 500 million passengers flying every year, Europe accredits to have the world’s busiest airspace. The economic stability in the region is helping the airliners and the booking platform providers to focus on providing various travel services to enhance the passenger’s experience. The Europe market is witnessing significant growth during the forecast period. For Holistic Research Report Click here @  https://bit.ly/3nOjUhh The airline sector is witnessing the high number of travelers from the North American region. The rate almost twice that of visitors from the Americas and Europe over the past ten years. Increasing disposable income especially in the US and Canada along with rising time constraints among the US and Canadian individuals ha...
Post a Comment
Read more

Generative AI: A Catalyst for Industrial Revolution

  Hype of Generative AI Generative AI is not just a fleeting trend; it's atransformative force that's been captivating global interest. Comparable in significance to the dawn of the internet, its influence extends across various domains, altering the way we search, communicate, and leverage data. From enhancing business processes to serving as an academic guide or a tool for crafting articulate emails, its applications are vast. Developers have even begun to favor it over traditional resources for coding assistance. The term Retrieval Augmented Generation (RAG), introduced by Meta in 2020 ( 1 ), is now familiar in the corporate world. However, the deployment of such technologies at an enterprise level often encounters hurdles like task-specificity, accuracy, and the need for robust controls. Why enterprises struggle with Industrializing Generative AI Despite the enthusiasm, enterprises are grappling with the practicalities of adopting Generative AI. According to survey by  MLI...
Post a Comment
Read more